Clinical Oncology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Research results from D. Haidopoulos and co-authors update knowledge of cervical cancer
August 3rd, 2009
According to recent research published in the journal Reproductive Sciences, "To assess the role of p 16(INK4A), bcl-2, and p53 in cervical cancer screening, we conducted a retrospective trial of prospectively collected data. Sixty two women with abnormal Pap smears were subjected to colposcopy and biopsies from any abnormal lesion." "Human papillomavirus (HPV)-DNA typing, histology, and immunochemistry for p16(IVK4A), bcl-2, and p53 were performed for these women. Histologic diagnosis was that of low grade squamous intraepithelial lesion (LSIL), high grade squamous intraepithelial lesion (HSIL), or cancer in all cases. Human papillomavirus strains were...
Source: Clinical Oncology Week (2009-08-03)
|
